certify

Anca Spanu Anca's career in journalism spans over 2 decades. She has served as staff writer, editor and deputy chief editor at various media outlets all over the world. At Healthcare Weekly, Anca writes about current events, innovations in the healthcare space and events/ conferences with a focus on investing & startups.

October 2, 2019 4157 Views
Novo Nordisk announced on September 20th U.S. Food and Drug Administration (FDA) approval for Rybelsus® (semaglutide) tablets 7 ...
banner
Adsense